Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Sjoukje F. Oosting"'
Autor:
Saskia H. Hanemaaijer, Iris C. Kok, Rudolf S. N. Fehrmann, Bert van der Vegt, Jourik A. Gietema, Boudewijn E. C. Plaat, Marcel A. T. M. van Vugt, Marije R. Vergeer, C. René Leemans, Johannes A. Langendijk, Jens Voortman, Jan Buter, Sjoukje F. Oosting
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Chemoradiotherapy (CRT) including three cycles of cisplatin is considered the standard of care for locally advanced head and neck squamous cell carcinoma (LA-HNSCC). However, around one-third of the patients cannot complete cisplatin beca
Externí odkaz:
https://doaj.org/article/41c85e17066d44cbaa8705b2b5208976
Autor:
Max J. H. Witjes, Roel J H M Steenbakkers, Bart Dorgelo, Boudewijn E. C. Plaat, Maran Fazzi, Bernard F. A. M. van der Laan, Bert van der Vegt, Gilles N. Stormezand, Saskia H Hanemaaijer, Sjoukje F. Oosting
Publikováno v:
Clinical Otolaryngology, 45(5), 805-810. Wiley
Clinical Otolaryngology
Clinical Otolaryngology
Autor:
Roel J H M Steenbakkers, Johannes A. Langendijk, Arjen van der Schaaf, Gyorgy B. Halmos, Tineke W.H. Meijer, Lisa Van den Bosch, E. Oldehinkel, Max J. H. Witjes, Johanna G M van den Hoek, Sjoukje F. Oosting, Hans Paul van der Laan
Publikováno v:
International Journal of Radiation Oncology, Biology, Physics, 111(2), 456-467. ELSEVIER SCIENCE INC
Purpose: Radiation therapy is an effective but burdensome treatment for head and neck cancer (HNC). We aimed to characterize the severity and time pattern of patient-reported symptoms and quality of life in a large cohort of patients with HNC treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::328e545e22645a0beacfc6a9bceab8cf
https://research.rug.nl/en/publications/587e50dc-105e-44cc-b971-4fdaf8777629
https://research.rug.nl/en/publications/587e50dc-105e-44cc-b971-4fdaf8777629
Autor:
Max J. H. Witjes, Sjoukje F. Oosting, Roel J H M Steenbakkers, Lisanne V. van Dijk, Walter Noordzij, Gyorgy B. Halmos, Tian-Tian Zhai, Johannes A. Langendijk, Nanna M. Sijtsema
Publikováno v:
Oral Oncology, 95, 178-186. ELSEVIER SCIENCE BV
Objectives: The aim of this study was to investigate whether quantitative CT image-biomarkers (IBMs) can improve the prediction models with only classical prognostic factors for local-control (LC), regional-control (RC), distant metastasis-free survi
Autor:
Boudewijn E. C. Plaat, Johannes A. Langendijk, Marcel A. T. M. van Vugt, Marije R. Vergeer, Sjoukje F. Oosting, Rudolf S N Fehrmann, Saskia H Hanemaaijer, Jourik A. Gietema, Iris C. Kok, Jan Buter, C. René Leemans, Jens Voortman, Bert van der Vegt
Publikováno v:
Hanemaaijer, S H, Kok, I C, Fehrmann, R S N, van der Vegt, B, Gietema, J A, Plaat, B E C, van Vugt, M A T M, Vergeer, M R, Leemans, C R, Langendijk, J A, Voortman, J, Buter, J & Oosting, S F 2020, ' Comparison of Carboplatin With 5-Fluorouracil vs. Cisplatin as Concomitant Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma ', Frontiers in Oncology, vol. 10, 761 . https://doi.org/10.3389/fonc.2020.00761, https://doi.org/10.3389/fonc.2020.00761
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, 10:761. Frontiers Media SA
Frontiers in Oncology
Frontiers in Oncology, 10:761. Frontiers Media S.A.
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, 10:761. Frontiers Media SA
Frontiers in Oncology
Frontiers in Oncology, 10:761. Frontiers Media S.A.
Background: Chemoradiotherapy (CRT) including three cycles of cisplatin is considered the standard of care for locally advanced head and neck squamous cell carcinoma (LA-HNSCC). However, around one-third of the patients cannot complete cisplatin beca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d39ccbb3e7ae55bfd5c25461ff3b4163
https://research.vumc.nl/en/publications/f898cfe9-e838-4b4a-92b6-27f6d6319720
https://research.vumc.nl/en/publications/f898cfe9-e838-4b4a-92b6-27f6d6319720
Autor:
Z. Lin, Charlotte L. Brouwer, Max J. H. Witjes, Lisanne V. van Dijk, Roel J H M Steenbakkers, Johannes A. Langendijk, Tian-Tian Zhai, Cássia O. Ribeiro, Nanna M. Sijtsema, Gyorgy B. Halmos, Bao-Tian Huang, Sjoukje F. Oosting
Publikováno v:
Radiotherapy and Oncology, 124(2), 256-262. ELSEVIER IRELAND LTD
Purpose: To develop and validate prediction models of overall survival (OS) for head and neck cancer (HNC) patients based on image biomarkers (IBMs) of the primary tumor and positive lymph nodes (Ln) in combination with clinical parameters.Material a
Autor:
Phil W. Koken, Hendrik P. Bijl, C. René Leemans, Ben J. Slotman, O. Chouvalova, Miranda E.M.C. Christianen, Irma M. Verdonck-de Leeuw, Sjoukje F. Oosting, Johannes A. Langendijk, Jan L. N. Roodenburg, Bernard F. A. M. van der Laan, Patricia Doornaert, Roel J H M Steenbakkers
Publikováno v:
Radiotherapy and Oncology, 117(1), 139-144. ELSEVIER IRELAND LTD
Radiotherapy and Oncology, 117(1), 139-144. Elsevier Ireland Ltd
Christianen, M E M C, Verdonck-de Leeuw, I M, Doornaert, P, Chouvalova, O, Steenbakkers, R J H M, Koken, P W, Leemans, C R, Oosting, S F, Roodenburg, J L N, van Laan, B F A M, Slotman, B J, Bijl, H P & Langendijk, J A 2015, ' Patterns of long-term swallowing dysfunction after definitive radiotherapy or chemoradiation. ', Radiotherapy and Oncology, vol. 117, no. 1, pp. 139-144 . https://doi.org/10.1016/j.radonc.2015.07.042
Radiotherapy and Oncology, 117(1), 139-144. Elsevier Ireland Ltd
Christianen, M E M C, Verdonck-de Leeuw, I M, Doornaert, P, Chouvalova, O, Steenbakkers, R J H M, Koken, P W, Leemans, C R, Oosting, S F, Roodenburg, J L N, van Laan, B F A M, Slotman, B J, Bijl, H P & Langendijk, J A 2015, ' Patterns of long-term swallowing dysfunction after definitive radiotherapy or chemoradiation. ', Radiotherapy and Oncology, vol. 117, no. 1, pp. 139-144 . https://doi.org/10.1016/j.radonc.2015.07.042
Objectives: To identify patterns of long-term, radiation-induced swallowing dysfunction after definitive radiotherapy with or without chemotherapy (RT or CHRT) and to determine which factors may explain these patterns over time.Material and methods:
Autor:
A. Gawryszuk, Hans Paul van der Laan, Hendrik P. Bijl, Jan L. N. Roodenburg, Johannes A. Langendijk, Johanna G. M. Vemer-van den Hoek, K. Wopken, Arjen van der Schaaf, Bernard F. A. M. van der Laan, Sjoukje F. Oosting, Roel J H M Steenbakkers, O. Chouvalova
Publikováno v:
Radiotherapy and Oncology, 115(1), 56-62. ELSEVIER IRELAND LTD
PURPOSE: To determine if acute symptoms during definitive radiotherapy (RT) or chemoradiation (CHRT) are prognostic factors for late dysphagia in head and neck cancer (HNC).MATERIAL AND METHODS: This prospective cohort study consisted of 260 HNC pati
Autor:
Charlotte Brouwer, Johannes A. Langendijk, Gyorgy B. Halmos, Erwin M. Wiegman, Vikram R. Bollineni, Michel Koole, Sjoukje F. Oosting, Joachim Widder, Harry J.M. Groen, Roel J H M Steenbakkers, Jan Pruim, Renske Vlasman
Publikováno v:
Radiotherapy and Oncology, 113(2), 198-203. ELSEVIER IRELAND LTD
INTRODUCTION: To define the optimal time point for the integration of hypoxia (18)F-FAZA-PET/CT information into radiotherapy treatment planning to benefit from hypoxia modification or dose escalation treatment. Therefore, we performed a prospective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68e7623449c6764e39f9d121acea484c
https://research.rug.nl/en/publications/34ba1261-6dd4-4374-b1da-c42720e26cab
https://research.rug.nl/en/publications/34ba1261-6dd4-4374-b1da-c42720e26cab
Autor:
Patricia Doornaert, K. Wopken, Johannes A. Langendijk, Roel J H M Steenbakkers, Ben J. Slotman, Irma M. Verdonck-de Leeuw, Hans Paul van der Laan, C. René Leemans, Arjen van der Schaaf, Hendrik P. Bijl, Miranda E.M.C. Christianen, Jan L. N. Roodenburg, Bernard F. A. M. van der Laan, Sjoukje F. Oosting, O. Chouvalova
Publikováno v:
Wopken, K, van der Schaaf, A, van der Laan, H P, Chouvalova, O, Steenbakkers, R J, Doornaert, P, Slotman, B J, Oosting, S F, Christianen, M E, van der Laan, B F, Roodenburg, J L, Leemans, C R, Verdonck-de Leeuw, I M & Langendijk, J A 2014, ' Development of a multivariable normal tissue complication probability (NTCP) model for tube feeding dependence after curative radiotherapy/chemo-radiotherapy in head and neck cancer. ', Radiotherapy and Oncology, vol. 113, no. 1, pp. 95-101 . https://doi.org/10.1016/j.radonc.2014.09.013
Radiotherapy and Oncology, 113(1), 95-101. Elsevier Ireland Ltd
Radiotherapy and Oncology, 113(1), 95-101. ELSEVIER IRELAND LTD
Radiotherapy and Oncology, 113(1), 95-101. Elsevier Ireland Ltd
Radiotherapy and Oncology, 113(1), 95-101. ELSEVIER IRELAND LTD
Background and purpose: Curative radiotherapy/chemo-radiotherapy for head and neck cancer (HNC) may result in severe acute and late side effects, including tube feeding dependence. The purpose of this prospective cohort study was to develop a multiva